| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| | | IP | CI | | Cefuroxim Sandoz 500mg | 14 | 15.00 | 32.75 | 10 % | | Coated tablets: Cefuroximum 500 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | | IP | CI | | Cefuroxim Sandoz 250mg - T | 14 | PR | PR | k.A. | | Coated tablets: Cefuroximum 250 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | CI | | Cefuroxim Sandoz 250mg - T | 10 x 14 | PR | PR | k.A. | | Coated tablets: Cefuroximum 250 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | CI | | Cefuroxim Sandoz 500mg | 10 x 14 | PR | PR | k.A. | | Coated tablets: Cefuroximum 500 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | | | Zinacef 750 mg | Durchstechflasche(n) | 4.12 | 13.70 | 10 % | | Dry substance: Cefuroximum 750 mg | Sandoz
Pharmaceuticals AG | A / SL / SO | FB | | G | |
| | | IP | | | Zinacef 1.5 g | Durchstechflasche(n) | 7.05 | 16.90 | 10 % | | Dry substance: Cefuroximum 1.5 g | Sandoz
Pharmaceuticals AG | A / SL / SO | FB | | G | |
| | | IP | CI | | Zinat 250 mg - T | 14 Tablet(s) | 9.42 | 26.65 | 10 % | | Coated tablets: Cefuroximum 250 mg | Sandoz
Pharmaceuticals AG | A / SL / SO | FB | | G | |
| | | IP | CI | | Zinat 500 mg ‐ I | 14 Tablet(s) | 16.49 | 34.25 | 10 % | | Coated tablets: Cefuroximum 500 mg | Sandoz
Pharmaceuticals AG | A / SL / SO | FB | | G | |
| | | IP | CI | | Cefuroxim axapharm 250 mg | 14 Tablet(s) | 9.15 | 26.35 | 10 % | | Coated tablets: Cefuroximum 250 mg | axapharm ag | A / SL / SG | FB | | G | |
| | | IP | CI | | Cefuroxim axapharm 500 mg | 14 Tablet(s) | 15.00 | 32.75 | 10 % | | Coated tablets: Cefuroximum 500 mg | axapharm ag | A / SL / SG | FB | | G | |
| | | IP | CI | | Cefuroxim Spirig HC 250 mg | 14 Tablet(s) | 9.15 | 26.35 | 10 % | | Coated tablets: Cefuroximum 250 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Cefuroxim Spirig HC 500 mg | 14 Tablet(s) | 15.00 | 32.75 | 10 % | | Coated tablets: Cefuroximum 500 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Cefuroxim-Mepha 250 | 14 Tablet(s) | 9.15 | 26.35 | 10 % | | Coated tablets: Cefuroximum 250 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Cefuroxim-Mepha 500 | 14 Tablet(s) | 15.00 | 32.75 | 10 % | | Coated tablets: Cefuroximum 500 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Zinat | 70 ml | 8.14 | 25.25 | 10 % | | Granulat zur Herstellung einer Suspension zum Einnehmen: Cefuroximum 125 mg | Sandoz
Pharmaceuticals AG | A / SL | FB | | G | |
| | | IP | | | Cefuroxim Fresenius i.v. 750 mg | Durchstechflasche(n) à 15 ml | PR | PR | k.A. | | Dry substance: Cefuroximum 750 mg | Fresenius Kabi
(Schweiz) AG | A | FB | | G | |
| | | IP | | | Cefuroxim Fresenius i.v.
1500 mg | Durchstechflasche(n) à 20 ml | PR | PR | k.A. | | Dry substance: Cefuroximum 1500 mg | Fresenius Kabi
(Schweiz) AG | A | FB | | G | |
| | | IP | CI | | Cefuroxim-Acino 250 mg | 14 | PR | PR | k.A. | | Coated tablets: Cefuroximum 250 mg | Acino Pharma AG | A | FB | | G | |
| | | IP | CI | | Cefuroxim-Acino 500 mg | 14 | PR | PR | k.A. | | Coated tablets: Cefuroximum 500 mg | Acino Pharma AG | A | FB | | G | |
| | | IP | | | Cefuroxim Labatec i.v. 750 mg | 750 mg | PR | PR | k.A. | | poudre pour solution injectable: Cefuroximum 750 mg | Labatec Pharma SA | A | FB | | G | |
| | | IP | | | Cefuroxim Labatec i.v. 750 mg | 10 x 750 mg | PR | PR | k.A. | | poudre pour solution injectable: Cefuroximum 750 mg | Labatec Pharma SA | A | FB | | G | |
| | | IP | | | Cefuroxim Labatec i.v. 1,5 g | 1.5 g | PR | PR | k.A. | | poudre pour solution injectable/pour perfusion: Cefuroximum 1500 mg | Labatec Pharma SA | A | FB | | G | |
| | | IP | | | Cefuroxim Labatec i.v. 1,5 g | 1.5 g | PR | PR | k.A. | | poudre pour solution injectable/pour perfusion: Cefuroximum 1500 mg | Labatec Pharma SA | A | FB | | G | |
| | | IP | | | Cefuroxim Labatec i.v. 1,5 g | 10 x 1.5 g | PR | PR | k.A. | | poudre pour solution injectable/pour perfusion: Cefuroximum 1500 mg | Labatec Pharma SA | A | FB | | G | |
| | | IP | | | Cefuroxim Labatec i.v. 1,5 g | 10 x 1.5 g | PR | PR | k.A. | | poudre pour solution injectable/pour perfusion: Cefuroximum 1500 mg | Labatec Pharma SA | A | FB | | G | |
| | | IP | CI | | Cefurox Actavis 125 mg | 14 Tablet(s) | 6.03 | 15.10 | k.A. | | Coated tablets: Cefuroximum 125 mg | Actavis Switzerland AG | A | FB | | G | |
| | | IP | CI | | Cefurox Actavis 125 mg | 14 Tablet(s) | PR | PR | k.A. | | Coated tablets: Cefuroximum 125 mg | Actavis Switzerland AG | A | FB | | G | |
| | | IP | CI | | Cefurox Actavis 250 mg | 14 Tablet(s) | 10.99 | 20.80 | k.A. | | Coated tablets: Cefuroximum 250 mg | Actavis Switzerland AG | A | FB | | G | |
| | | IP | CI | | Cefurox Actavis 250 mg | 14 Tablet(s) | PR | PR | k.A. | | Coated tablets: Cefuroximum 250 mg | Actavis Switzerland AG | A | FB | | G | |
| | | IP | CI | | Cefurox Actavis 500 mg | 14 Tablet(s) | 17.69 | 36.70 | k.A. | | Coated tablets: Cefuroximum 500 mg | Actavis Switzerland AG | A | FB | | G | |
| | | IP | CI | | Cefurox Actavis 500 mg | 14 Tablet(s) | PR | PR | k.A. | | Coated tablets: Cefuroximum 500 mg | Actavis Switzerland AG | A | FB | | G | |
